chrisvoncsefalvay/vaers-outcomes huggingface dataset:
fever; Itchy bumps; Blister; left arm pain radiated to her elbow and up to her neck; Neck pain; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 78-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 22nd August 2019, the patient received the 2nd dose of Shingrix. On 22nd August 2019, less than a day after receiving Shingrix, the patient experienced pain in arm and neck pain. On 23rd August 2019, the patient experienced fever, itchy rash and blister. The patient was treated with ibuprofen. On an unknown date, the outcome of the pain in arm, neck pain, fever, itchy rash and blister were unknown.   It was unknown if the reporter considered the pain in arm, neck pain, fever, itchy rash and blister to be related to Shingrix.  Additional information received were as follows: The patient received Shingrix on left arm. On the same day of vaccination, the patient experienced left arm pain which radiated to her elbow and up to her neck for which she took ibuprofen and this resolved. 1 day after receiving Shingrix, the patient experienced slight fever and took ibuprofen and this resolved. The patient stated that from Friday, 1 day after receiving Shingrix, she experienced bumps which started near the elbow of the left arm which spread to left wrist, then near her right eye, then wrist of the right arm, then hair line, then near nose, then near right eye brow and then the back of the neck and blisters. The bumps were ongoing.  The patient stated these bumps were itchy.  The reporter consented to follow up.
On 9/18 returned to clinic, erupted with rash from head to toe, (date of rash onsest not specified). Had fever a few days prior to rash. On 9/20 rash, head to toe. Small raised bumps, not blisters. Still had low grade fever. Treated with Bactriban and Zyrtec and improved.
Suspected vaccination failure/Had shingles vaccinated, also have has shingles; Had shingles vaccinated, also have has shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included chickenpox (had chick pox as child ).   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 24-Jul-2022 Reporter's comment: The case was received from the patient via interactive digital media. The patient had shingles vaccinated and also have had shingles. The patient stated that although it was a difficult experience. It could have been worst. The patient also mentioned that age was not necessarily a factor, check with the medical profession. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
fever; fatigue; headache; Chills; nausea; vomiting; Muscle pain; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), PYREXIA (fever), FATIGUE (fatigue) and HEADACHE (headache) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 042B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Apr-2021, the patient experienced MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), CHILLS (Chills) and NAUSEA ( nausea). 14-Apr-2021, the patient experienced VOMITING (vomiting). On 19-Apr-2021, the patient experienced PYREXIA (fever) and FATIGUE (fatigue). 19-Apr-2021, the patient experienced HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form and PROMETHAZINE (PHENERGAN [PROMETHAZINE]) at a dose of 1 dosage form. On 17-Apr-2021, MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), CHILLS (Chills), NAUSEA ( nausea) and VOMITING (vomiting) had resolved. On 21-Apr-2021, PYREXIA (fever) and FATIGUE (fatigue) had resolved and HEADACHE (headache) outcome was unknown.            No concomitant medication were provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-084205 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Significant Followup Appended. 2nd dose was updated.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-084205:Case for dose 2 of Husband
MD reports that 6 pts who recvd 3 doses of HEp B vax ID did not convert; recvd 2 booster doses of Engerix-B;
Mother reports child complained of a headache (severe) at approximately 8 PM along with slight irritability. Given Advil with relief of symptom approximately 915 PM. Slept through the night; woke in the AM without complaints.
Narrative:  71 y/o male w/ PMH for HTN, Asthma, HLD, Lumbago, CKD, and HF. Pt presented to the ED on 06/04/22 with SOB worsening over 5 days. Pt admitted to hospital ICU w/ acute hypoxic respiratory failure secondary to heart failure with reduced ejection fraction exacerbation. Pt also treated for Acute kidney injury on CKD 4, pulmonary hypertension, hypertensive urgency, anemia secondary to chronic disease and COVID-19 infection. Pt treated with dexamethasone (06/4-06/05) and supportive treatment during hospital stay for COVID. Pt improved and discharged to home on 06/14.
It is hot and has been sore; Now it is only a little bit tender; Itchy red rash in the injection site; It is hot and has been sore; Itchy red rash in the injection site; Itchy red rash in the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (It is hot and has been sore), TENDERNESS (Now it is only a little bit tender), VACCINATION SITE PRURITUS (Itchy red rash in the injection site), INJECTION SITE PAIN (It is hot and has been sore) and VACCINATION SITE ERYTHEMA (Itchy red rash in the injection site) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was reported.  Concomitant products included PARACETAMOL (TYLENOL) for Arthritis.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced INJECTION SITE WARMTH (It is hot and has been sore), TENDERNESS (Now it is only a little bit tender), VACCINATION SITE PRURITUS (Itchy red rash in the injection site), INJECTION SITE PAIN (It is hot and has been sore), VACCINATION SITE ERYTHEMA (Itchy red rash in the injection site) and VACCINATION SITE RASH (Itchy red rash in the injection site). At the time of the report, INJECTION SITE WARMTH (It is hot and has been sore), TENDERNESS (Now it is only a little bit tender), VACCINATION SITE PRURITUS (Itchy red rash in the injection site), INJECTION SITE PAIN (It is hot and has been sore), VACCINATION SITE ERYTHEMA (Itchy red rash in the injection site) and VACCINATION SITE RASH (Itchy red rash in the injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (unknown), the reporter did not provide any causality assessments.  Concomitant medications also  included allergy pill, heart palpitations medicine and blood pressure medicine (unspecified).  The patient applied a lotion to moisture the skin but was not very effective for the symptoms.
After 30 mins, my lower lip started tingling and  became numb.  In 15 mins, my left side of my face was numb and tingling.  It then spread to the right side. My throat started itching and then my ears began itching.  I then got a headache.  I contacted my primary dr office. They would not see me because they didn't give the shot. I text my allergy office. They told me to take Benadryl and keep my epi pen close. I did. After an hour and a half, the symptoms didn't improve so I decided to go to the Urgent Care.  By this time, the numbing/ tingling feeling was going down my arms and back. They said my blood pressure was a little high and I had a slight fever, 99,8.  I  felt awful.  The urgent care said there wasn't anything they could do but recommend continual use of benadryl and ibeprophen.  I went home and rested.  The numbness and tingling lasted until around 5:00.  The itchy throat/ears and bad headache continued until I went to sleep around 9:30. I slept through the night. All symptoms were gone except for a sore arm, in the morning.
Patient reports Disoriented, patient feels like she was drugged, dizziness, facial numbness on the lft side, especially on the cheek, coming from neck. Back of head. numbness and tingling feeling on the back of the head and both arms and the hands. Patient reports headache as well. Also feeling fatigued
Horrible heart burn and GERD started the evening of my second Moderna shot- it has NOT stopped. Ive had to go on medicine - tried three different ones.   I?m taking twice a day Omeprazole 20mg.   Its very painful- Ive changed my diet, and still not helping.. Its Bad???..
Began with shooting sharp pains in left foot gradually going up my left leg. At that point I took aleve and a trazadone in hopes of getting some rest. I fell asleep. I woke up around 0200 on 1/13/21 with extreme muscle and joint aches, a sensation of pins, needles, and tingling all over my body I felt very jittery and was actually shaking slightly throughout the ordeal. I felt like my nervous system was overloaded and my perception of pain was extremely heightened. At one point during this 4 hour period I had a visual hallucination. By 0600 I was feeling better- more relaxed. Muscle aches and sore joints are still present today. Also have a slight increase in temp 99.6 and injection site pain.
Dose administered after 30-day Use By Date or after manufacturer date of expiry; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry ) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050E21A) for COVID-19 vaccination.     No Medical History information was reported.    In November 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In November 2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry ). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry ) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. The vial was initially stored in the refrigerator on 04-Nov-2021. The vial did not undergo any temperature excursions. It was reported that the patient had no adverse event (AE) as a result of this misadministration and was monitored. Some of the vaccines were administered on 05-Nov-2021 and some on 12-Nov-2021. No treatment information was reported.
While injecting the client with her 2nd moderna dose the vaccinator noted that vaccine leaked from the junction between the needle and the syringe. The client did not receive the full dose of the vaccine. The client was notified of the incident.
PCV 13 vaccination to (R) arm pt c/o arm red/itchy, mild edema.
CLIENT RECEIVED 7 VACCINES ON THE 26 OF MARCH. CLIENT HAD POSITIVE PREGNANCY TEST TODAY IN OUR ADULT HEALTH CLINIC.
Significant pain around heart and in chest cavity and tightness in chest cavity and throat.  This happened about 10 minutes after shot.  Blurry vision for about 1-2 hours and very fatiqued for evening and next day. Very fuzzy headed for a few days.
It was reported in a published article, titled as above.  A 26 year old woman came to a family practice clinic to receive the first of three doses of GARDASIL.  She returned 5 days later with swollen lymph nodes in the left side of her neck.  The patient noticed enlarging lymph nodes 3 days after receiving the GARDASIL, which had been injected intramuscularly into her left deltoid muscle.  At this visit and all sequent clinic visits, the patient denied any recent upper respiratory infection, pharyngitis, cough, fever, or left upper extremity skin infections or rashes.  She also denied any significant medical or surgical history.  Her drug therapy only consisted of a daily oral contraceptive, and she denied recent antibiotic and nonsteroidal antiinfammatory treatment.  She had received no other immunizations recently and reported no previous vaccine-related lymphadenopathy.  The patient also denied any drug or seasonal allergies, asthma, or eczema.  Physical examination revealed normal vital signs and several palpable anterior cervical and supraclavicular subcentimeter lymph nodes on the left side of the patient's neck.  These were soft and fully mobile, without matting.  The remainder of her physical examination was normal with no other regional lymphadenopathy.  Due to the patient's lack of systemic symptoms, laboratory evaluation, pharmacologic therapy, and lymph node biopsy were not indicated.  The patient remained afebrile and exhibited no signs or symptoms of systemic infection over the next several days.  She was reevaluated at the family practice office 17 days after her initial vaccination.  The lymphadenopathy had completely resolved.  The patient received her second dose of GARDASIL 2 months after the initial immunization and experienced no associated lymphadenopathy.  This patient's lymphadenopathy was spatially and temporally related to administration of GARDASIL, given that it developed in the left side of her neck, ipsilateral to the vaccination site, within 3 days of immunization.  Her history and physical examination suggested no other possible etiology of lymphadenopathy such as infection, cancer, autoimmune disease, or immunocompromised status.  Therefore, one can reasonably conclude, congruent with the score derived from an adverse drug reaction probability scale, that the patient's unilateral cervical lymphadenopathy was most likely caused by the GARDASIL.  We concluded that withholding further GARDASIL immunization or any other recommended or indicated vaccines would not be necessary since lymphadenopathy is not a life-threatening adverse effect and poses no serious consequences.  Additional information is not expected.
Itchy, red, rheumy eyes.  2 weeks after, still with eye discomfort and redness, but not as much itching. Also an onset of joint pain after 12 days, unknown if this is related. Increase in palpitations
Addisons crisis- low blood pressure, short of breath, weakness, dizziness, low oxygen level, elevated lactic acid Treated in ER with IV hydrocortisone and fluids Admitted for observation and fluids Magnesium IV because level was low Hospitalized 24hrs
Significant breakthrough menstrual bleeding hours following vaccination. This has happened with all 4 covid vaccines received and lasted about 8 months after last shot received. It is not normal menstrual bleeding with clots, it is copious amounts of red blood. Prior to getting vaccinated I had a period around every 30 days, now it is more frequent around every 16-22 days with significantly more bleeding.
Patient received PCV 13 on (R) thigh on 12/2/10 and few hours later was c/o pain at site next day she was refusing to walk. O/E: Pt has no obvious redness, min fullness of thigh at site with little tenderness.
First time I read the side effects was this a.m.  I have 2 big welts one on and below the injection site.  Tired, muscle pain that shot all over the body.  Went across chest, then in lower back, calves, hip, forearms, then center of knee, the spine, shoulders, hands, tops of feet, toes.  nausea, somach pain, fever, shivering, head - 2 days.   Felt like body was under attack.  Took 1 tyelenol. able to sleep for about 90 mins. woke up again.  Continued all night.   Today for first time I feel like me again.   This is the second does of zoster.  wondering if there is a base ingredient that may have a sensitivity.  Please call if wanting to discuss further.  It was  really brutal.
HAS A HARD KNOT WITH REDNESS. ITCHY AND WARM TO TOUCH.
Information has been reported in a study. The report includes VAERS reports following PNEUMOVAX 23 or Pneumococcal polysaccharide vaccine (PPSV23) brand unknown after 2002. The report includes reports information from 01-JAN-1990 to 31-JAN-2014. This spontaneous report as received from a other health professional refers to 2 patients. The median age of the patients was 69 years old; range being 23 to 98 years. Between 01-JAN-1990 and 31-DEC-2013 patients were vaccinated with PNEUMOVAX 23. On an unknown date the patients experienced death. The outcome of death was reported as fatal. The cause of death was reported as neurological. The death of the patients was confirmed with medical records, autopsy reports and/or death certificates. The report has been split into cases according to cause of death. This case is linked to same reporter linked cases 1406USA003857 (respiratory disorder), 1406USA003863 (Unknown), 1406USA003859 (other non infectious disorder), # 1406USA003860 (gastrointestinal), 1406USA003858 (other infectious), # 1406USA003862 (Undetermined) and 1406USA003351 (Cardiovascular). Additional information has been requested.
Patient became lightheaded 5-10 minutes after the vaccination. Placed patient in supine position, raised lower extremities for about 20 minutes under observation by EMS. Blood Pressure and pulse were low. She had not had much food or beverage all day and has had such episodes before. Felt better, ambulated, and left. Returned for second dose 02/12/2021, observed uneventfully  for 30 minutes.
Injection site pain, no swelling or redness Fatigue (moderate) Headache Pain with eye movements  Nausea Abdominal pain No treatments needed.
This spontaneous report was received from a nurse practitioner and refers to an unspecified patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 28-JAN-2017, the patient was vaccinated with the improperly stored dose of PROQUAD subcutaneously (dose was not reported) (lot # M031568, expiration date 24-DEC-2017) for prophylaxis. There were no adverse effects reported. Administered dose of vaccine experienced the temperature excursion greater than 5 degrees Fahrenheit and less than 14 degrees Fahrenheit (6.1 degrees Fahrenheit) for 41 hours and 20 minutes. Data logger was involved. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1702USA004122: US-009507513-1702USA004127: US-009507513-1702USA004124: US-009507513-1702USA004125: US-009507513-1702USA004126: US-009507513-1702USA001032: US-009507513-1702USA004123: US-009507513-1702USA004176:
SCA (Spin Cerebellar Ataxia) care given came in requesting Meningococcal Inj per Dr request 2 mins after receiving the injection he became dizzy, lethargic and perfusely sweating. We called 911 and pt began to gain consciousness approximately 10 mins later. He had not eating (his stomach was empty).
Starting at day three after the vaccination, I experienced significant fatigue.  I also have experienced significant and rather violet chills, shakes and teeth chattering.  The fatigue lasts all day.  The chills come on each afternoon and last for about an hour.  My temperature is 101 to 103 during  the event, but it is normal the rest of the day.  The fatigue and chills continue through today.
Hives; Joint pain/joints hurt really bad; Swelling of hands/hands swelled; Throat tightening/Her throat was closing a little; This is a spontaneous report from a contactable consumer (patient) via a Pfizer-sponsored program. An 18-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: FA6780), dose 1 via an unspecified route of administration, administered in Arm Left on 25Jul2021 (at the age of 18years) as dose 1, single  for Covid-19 immunization. There were no medical history and concomitant medications. On 26Jul2021, the patient was admitted to the ER (emergency room) with hives, joint pain, swelling of hands, and throat tightening. The hives started 12 hours after the vaccine (as reported). She started to get bad, and the swelling started so she went in. The hives started on her neck. Her hands swelled, her joints hurt really bad, and she had hives over her whole body. Her throat was closing a little. She was prescribed antihistamines by the doctor. It took away the hives in 3 days. Didn't do imaging or tests, blood test was done, but they didn't give her the results everything else was normal. She would like to know if Pfizer recommends her to take the second dose of the Pfizer COVID-19 vaccine or should she take another COVID-19 vaccine. She stated that she never had an allergy before, and the doctor told her the vaccine would be the cause of her reaction and that this reaction would be "pretty rare". The doctor at the ER did not want to provide a recommendation and advised patient to call Pfizer. The outcome of event hives was recovered on 29Jul2021; outcome of other events was unknown.  Follow-up attempts are completed. No further information is expected.
left arm feels like it is going to fall/left shoulder feels frozen; pain in left arm resolved and then recurred and the pain has traveled to hand; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in left arm resolved and then recurred and the pain has traveled to hand) and PERIARTHRITIS (left arm feels like it is going to fall/left shoulder feels frozen) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain in left arm resolved and then recurred and the pain has traveled to hand). On 05-Mar-2021, the patient experienced PERIARTHRITIS (left arm feels like it is going to fall/left shoulder feels frozen). At the time of the report, PAIN IN EXTREMITY (pain in left arm resolved and then recurred and the pain has traveled to hand) and PERIARTHRITIS (left arm feels like it is going to fall/left shoulder feels frozen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No treatment information was provided.